Prilenia Therapeutics is appointing Elisabeth (Lis) Leiderman, MD, MBA, as Chief Financial Officer (CFO). Background and Experience Leiderman has been CFO at several biotechnology companies, including Atsena, Decibel, and Dewpoint. Prilenia, a biopharmaceutical company, focuses on accelerating progress for people affected by Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS). Leiderman’s two decades-plus of experience also includes a current stint on the board of Autolus ...